ͼƬÃû³Æ

ÐÂÎÅ×ÊѶ

J9¼¯ÍÅ´´ÐÂÒ©Ñз¢ÔÙÍ»ÆÆ £¬WP103ÓÐÍûÌí²¹ÐÂÉú¶ùHIEÒ½ÖεÄÁÙ´²ÐèÒª£¡È«ÇòÁìÓò²»³É¶àµÃ»ñFDAË«È϶¨µÄÒ©Æ· £¬ÔÙ»ñINDÉêÇëÊÜÀí£¡

ÈÕÆÚ£º

2024Äê12ÔÂ30ÈÕ 12:52


ed908156-99cd-442a-b383-44daa60e6872

 

ÃÀ¹ú¶«²¿¹¦·ò12ÔÂ17ÈÕ £¬¹«Ë¾Ñз¢µÄ´´ÐÂÒ©ÐÂʯɼ¼î¼××¢ÉäÒº£¨WP103£©Õë¶ÔÐÂÉú¶ùȱÑõȱѪÐÔÄÔ²¡£¨HIE£©µÄÐÂÊÊÓ¦Ö¢µÄÁÙ´²ÊÔÑ飨IND£©ÉêÇë £¬»ñµÃÃÀ¹úʳƷҩƷ¼à¶½ÖÎÀí¾Ö£¨FDA£©ÊÜÀí £¬½øÈëרҵÉóÆÀ½×¶Î¡£

ÕâÒâζ×ÅJ9¼¯ÍŽ«ÎªÐÂÉú¶ùHIEÕâһȫÇò¼±ÐèÒ©ÎïÁÆ·¨µÄ¼²²¡ £¬µì¶¨Æô·¢ÐÔ×êÑеĻù´¡ £»Ò²±ê־ȡJ9¼¯ÍŶÔÖйúÔ­´´Ò©“ʯɼ¼î¼×”ÔÚÐÂÔì¼Á¡¢ÐÂÊÊÓ¦Ö¢´´ÐÂÑз¢¼°²¼¾ÖÈ«ÇòÊг¡µÄÓÖÒ»´ó³É¾Í¡£

 

 

 

¹ØÓÚÐÂÉú¶ùȱÑõȱѪÐÔ£¨HIE£©

HIEÊÇÓÉÐÂÉú¶ùÄÔ×é֯ȱÑõºÍÄÔѪÁ÷Á¿Ï÷¼õÒýÆðµÄÒ»ÖÖÐÂÉú¶ùÄÔΣÏÕ¼²²¡ £¬¶Ô·¢ÓýÖеĴóÄÔÓÐÑϳÁÓ°Ïì £¬²¢¿ÉÄܵ¼ÖÂÏÔÖøµÄéæÃüÂʺͷ¢²¡ÂÊ¡£ÔÚÃÀ¹ú £¬HIEÿÄêÓ°ÏìԼβ»µ½10,000ÃûÓ¤¶ù £»È«ÇòÁìÓòÄÚ £¬Ã¿ÄêÔ¼75ÍòÓ¤¶ùî¾»¼ÖжȻò³Á¶ÈHIE £¬µ¼ÖÂÔ¼400,000ÃûÓ¤¶ù»¼ÓÐÉñ¾­·¢Óý×è°­¡£

Ŀǰ £¬ÃÀ¹úÉÐÎÞ»ñÅúÒ©ÎïÓÃÓÚÒ½ÖÎÐÂÉú¶ùHIE¡£Å¹ú¶ÈÕë¶ÔÐÂÉú¶ùÖгÁ¶ÈHIEµÄ³ß¶È¹ýÎʲ½ÖèÖ»ÄÜÊÇÒ½ÖÎÐÔµÍΣ¨TH£© £¬µ«½ÓÊÜ TH Ò½ÖεÄÖгÁHIEÐÂÉú¶ùÒÀÈ»»á¾­Àú¸²ÃðÐԵIJ¢·¢Ö¢£º48%µÄéæÃü»òÖжÈ/³Á¶È²Ð¼²¡£Òò¶ø £¬µ±ÐÂÉú¶ù²úÉúHIEʱ £¬¼«¶È¼±Ð谲ȫÓÐЧµÄÒ½ÖÎ £¬²¢ÇÒ¶ÔÓÚ²»ºÏÓÃÓÚTHµÄÇáÖ¢HIE²¡ÀýÒ²±ØÒªÓÐЧµÄÒ©ÎïÁÆ·¨¡£

 

 

 

¹ØÓÚWP103Õë¶ÔHIEµÄINDÉêÇë»ñµÃÃÀ¹úFDAÊÜÀí 

¹«Ë¾±¾´ÎµÄ³É¹¦µÝ½»ÓëÊÜÀí £¬ÊÇÒÔ¹«Ë¾Ñз¢Óë¼¼ÊõÍŶӷ¢Õ¹µÄ¸ßÖÊÁ¿¡¢ÇкÏFDAÓëICHÒªÇóµÄÁÙ´²Ç°Ò©Ñ§£¨Ô­ÁÏÒ©¡¢Ôì¼Á£©ºÍÒ©Àí¶¾Àí×êÑÐÊý¾ÝΪ»ù´¡¡£

¶àÏîÁÙ´²Ç°×êÑÐÏÔʾ £¬Ê¯É¼¼î¼×Ò½ÖÎÐÂÉú¶ùHIEDZÁ¦¾Þ´ó £¬Óе«Ô¸Í¨¹ý×ۺϵÄ×÷ÓûúÔìÀ´Ó¦¶ÔȱÑõȱѪµÄ²¡ÀíÉúÀíÌôÕ½ £¬¸ø»¼¶ù´øÀ´ÁÙ´²»ñÒæ £¬Ô̺¬µ¨¼îˮƽÌáÉý¡¢½µµÍÐ˷ܶ¾ÐÔ¡¢¸ÄÉÆÏßÁ£ÌåÖ°ÄÜ×è°­¡¢½µµÍÑ×Ö¢ºÍÏ÷¼õ´ÙÑ×ϸ°ûÒò×Ó (IL-6¡¢TNF-α ºÍ IL-1β) £¬½µµÍÑõ»¯Ó¦¼¤ £¬ÒÔ¼°Ï÷¼õÉñ¾­ÔªéæÃüµÈ¡£

Ê×Ò³ | J9¼¯ÍÅÓÐÏÞ¹«Ë¾¹ÙÍø

 

±¾´ÎÁÙ´²ÊÔÑéÉêÇëµÄÊÜÀí £¬ÊÇJ9¼¯ÍÅ´´ÐÂÒ©Ñз¢ÍŶÓÔÚÐÂÉú¶ùHIEÒ½ÖÎÁìÓòµÄÒ»ÃͽøÕ¹¡£

 

 

 

¹ØÓÚJ9¼¯ÍÅ´´ÐÂÒ©»ñÈ«ÇòÁìÓò²»³É¶àµÃFDAË«È϶¨µÄÓÅÊÆ

¹«Ë¾ÓÚ2024Äê4Ôµ׻ñµÃFDAÊÚÓèµÄʯɼ¼î¼×Ò½ÖÎÐÂÉú¶ùȱÑõȱѪÐÔÄÔ²¡£¨HIE£©µÄº±¼û¶ù¿Æ¼²²¡ÓÃÒ©È϶¨(rare pediatric disease designation £¬RPDD) £¬ÓÖÓÚ2024Äê5Ôµ׻ñµÃFDAÊÚÓèµÄÒ½ÖÎÐÂÉú¶ùHIEµÄ¹Â¶ùÒ©È϶¨(orphan drug designation, ODD)¡£×÷ΪȫÇòÁìÓòÄÚ²»³É¶àµÃµÄ»ñµÃFDAË«È϶¨µÄÒ©Æ· £¬RPDDºÍODDÈ·±£Á˸ßÁÙ´²¼ÛֵDZÁ¦µÄʯɼ¼î¼×µÄ¸ßóÒ×¼ÛÖµ £¬Ô̺¬£º´ÓÒ©Æ·»ñÅúÆðÍ·µÄ7ÄêµÄÊг¡×¨ÓªÈ¨(market exclusivity)¡¢ÐÂÒ©ÉêÇë(NDA)µÄÓÅÏÈÉóÆÀÉóÅú¡¢ÐÂÒ©NDA×¢²áÓöȵÄÃâÈ¥(Ô¼3000ÍòÈËÃñ±Ò) £¬ÒÔ¼°ÔÚÁÙ´²¿ª·¢¹ý³ÌÖиü¶àµÄFDAµÄÁìµ¼ÓëÖ§³Ö £¬¹²Í¬ÍƽøHIEÕâÒ»ÑϳÁºÍΣ¼°ÐÔÃüµÄ¶ù¿Æº±¼û¼²²¡Ò©ÎïµÄÑз¢¡£

±¾´ÎÉ걨µÄÐÂÉú¶ùHIEÊÊÓ¦Ö¢ £¬ÕâÒ»µ¼ÖÂÓ¤¶ùéæÃü¡¢³Á´ó²Ð¼²µÄÑϳÁ¼²²¡ £¬ÃÀ¹úÉÐÎÞ»ñÅúµÄÒ½ÖÎÒ©Îï £¬´æÔÚÑϳÁµÄδÂú×ãÁÙ´²ÐèÒª¡£¹«Ë¾ÒóÇе«Ô¸Ê¯É¼¼î¼×µÄÁÆÐ§ºÍ°²È«ÐÔ¿ÉÄܼ±¾çÔÚÁÙ´²ÉÏ»ñµÃÑéÖ¤ £¬´Ó¶øÌí²¹ÐÂÉú¶ùHIEÒ½ÖεÄÈ«ÇòÁÙ´²ÐèÒª¡£µÈ´ý¾ÍÁÙ´²ÊÔÑéµÄÉêÇë»ñµÃFDAµÄ»ý¼«·´À¡ £¬Íƶ¯WP103µÄ¼±¾ç¡¢¸ßÖÊÁ¿µÄÁÙ´²¿ª·¢ £¬ÔçÈÕ½«¸üºÃµÄÁÙ´²Ñ¡Ôñ´ø¸øÈ«ÇòǧǧÍòÍòÊÜHIEÍþвµÄ»¼¶ùºÍ¼ÒÍ¥¡£

 

 

¹ØÓÚJ9¼¯ÍÅÑз¢

J9¼¯ÍÅĿǰ½¨ÓÐÔ¼120È˵ÄÑз¢ÍŶÓ £¬¿ÉÄÜ·¢Õ¹È«¼ÛÖµÁ´µÄÒ©Æ·Ñз¢¹¤×÷ £¬´ÓÔçÆÚ·¢ÏÖµÄÉè¼Æ¡¢»¯Ñ§¡¢ÉúÎïѧ £¬µ½ IND-enablingµÄҩѧÓëÒ©Àí¶¾Àí×êÑÐ £¬ÒÔ¼°ÁÙ´²¿ª·¢µÄ¹æ»®ÓëÔËÓª¡£Í¬Ê± £¬¹«Ë¾½¨ÓÐԺʿ¹¤×÷Õ¾¡¢²©Ê¿ºó¹¤×÷Õ¾¡¢Ê¡¼¶¼¼Êõ¡¢Ñз¢ÖÐÐĵȶà¸ö¸ß¶Ëƽ̨ £¬ÎªÒ©Æ·Ñз¢ÌṩÐÛºñµÄÈ˲ÅÓëר¼ÒÖ§³Ö¡£

¹«Ë¾Ñз¢¹ÜÏß·á˶ £¬ÐγÉÁË´´ÐÂÒ©Ñз¢¡¢·ÂÔìÒ©Ñз¢¡¢Ô­ÁÏÒ©Ñз¢¡¢ÖÐÒ©Ñз¢ÆëÍ·²¢½øµÄ´óÑз¢ÏµÍ³Óë¸ñ¾Ö¡£ÆäÖÐ £¬´´ÐÂÒ©Ñз¢¾Û½¹£¨³Á´ó£©Éñ¾­ÏµÍ³¼²²¡¡¢´úл¡¢×ÔÌåÃâÒß¡¢º±¼û²¡µÈËÄ´óÁìÓò £¬¼½Íû³ä·Ö²ûÑ﹫˾¶àÄêµÄÊý¾Ý¶Ñ¼¯ £¬Îª»¼Õß´øÀ´ÁÙ´²Ø½ÐèµÄ´´ÐÂÁÆ·¨¡£

»ùÓÚ¶àÄêµÄÊý¾Ý¶Ñ¼¯ºÍ¶Ô´óÁ¿Êý¾ÝµÄ¶´²ì £¬J9¼¯ÍÅ´´ÐÂÒ©ÍŶÓÔÚÈ«ÇòÁìÓòÄÚ³õ´´»ñµÃʯɼ¼î¼×Ò½ÖÎÐÂÉú¶ùHIEµÄODDºÍRPDDµÄÈ϶¨ £¬²¢Ôڶ̹¦·òÄÚʵÏÖ¸ßÖÊÁ¿µÄÁÙ´²Ç°¹¤×÷ £¬»ñµÃFDAµÄINDÁÙ´²ÊÔÑéÉêÇëÊÜÀí £¬³ä·ÖÏÔʾÁ˳¬¸ßµÄÐÂÒ©Ñз¢ÄÜÁ¦ £¬ÒÔ¼°¼Ó¿ìÍÆ¶¯½â¾ö»¼Õߨ½ÐèµÄרҵÐÄÁé¡£

ÓйØÍƼö

¡¾ÍøÕ¾µØÍ¼¡¿